Published in Ann Surg on October 01, 1974
Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg (1978) 2.80
Major hepatic resection under total vascular exclusion. Ann Surg (1989) 2.29
Retroviral-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci U S A (1991) 1.87
Significant trends in the treatment of hepatic trauma. Experience with 411 injuries. Ann Surg (1992) 1.58
Experience with the finger fracture technique to achieve intra-hepatic hemostasis in 75 patients with severe injuries of the liver. Ann Surg (1983) 1.30
Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience. Ann Surg (2006) 1.28
Surgical management of carcinoma of the junction of the main hepatic ducts. Ann Surg (1976) 1.25
Evaluation of stapler hepatectomy during a laparoscopic liver resection. HPB (Oxford) (2013) 1.22
Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases. Ann Surg (2000) 1.18
In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann Surg (2005) 1.17
One hundred hepatic resections. Indications and operative results. Ann Surg (1985) 1.14
Inferior vena cava resection with hepatectomy: challenging but justified. HPB (Oxford) (2011) 1.06
Liver resection under total vascular isolation. Variations on a theme. Ann Surg (1993) 1.06
Recent concepts in the treatment of hepatic trauma: facts and fallacies. Ann Surg (1979) 1.03
Surgical treatment of hepatocellular carcinoma. Surg Today (2009) 0.97
Resection and reconstruction of the inferior vena cava for neoplasms. World J Gastrointest Surg (2012) 0.87
Comparison of major hepatectomy performed under intermittent Pringle maneuver versus continuous Pringle maneuver coupled with in situ hypothermic perfusion. World J Surg (2011) 0.83
Hypothermic in situ perfusion of the porcine liver using Celsior or Ringer-lactate solution. Langenbecks Arch Surg (2008) 0.81
Milestones in the evolution of hepatic surgery. Rambam Maimonides Med J (2011) 0.80
Blocking intrahepatic inflow and backflow using Chang's needle during hepatic resection: Chang's maneuver. HPB (Oxford) (2008) 0.80
Modern surgery for liver metastases. Cancer Imaging (2000) 0.80
Resection of an intra-operative ruptured hepatocellular carcinoma with continuous pringle maneuver and in situ hypothermic perfusion through the inferior mesenteric vein: a case report. World J Surg Oncol (2013) 0.75
Protective mechanisms of hypothermia in liver surgery and transplantation. Mol Med (2015) 0.75
Ante-situm resection: a novel approach to avoid extracorporeal circulation using a transient portacaval shunt. HPB (Oxford) (2014) 0.75
Ante situm liver resection with inferior vena cava replacement under hypothermic cardiopolmunary bypass for hepatoblastoma: Report of a case and review of the literature. Int J Surg Case Rep (2017) 0.75
Grey Turner Memorial Lecture. Changing role of liver surgeons. World J Surg (1999) 0.75
Mechanical intestinal cleansing and antibiotic prophylaxis for preventing bacterial translocation during the Pringle maneuver in rabbits. Surg Today (2011) 0.75
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Orthotopic and heterotopic liver homografts in man. Ann Surg (1970) 2.63
Metabolism before and after hepatic lobectomy for cancer. Studies in twenty-three patients. Arch Surg (1960) 2.12
Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy. Ann Surg (1973) 1.53
Cancer of the right lobe of the liver: a variety of operative procedures. Arch Surg (1972) 1.30
Major hepatic resection for malignant neoplasms of the liver. Ann Surg (1972) 1.25
Tumour in a single kidney: nephrectomy, excision, and autotransplantation. Lancet (1971) 1.09
Isolation and perfusion of the liver of cancer chemotherapy. J Surg Res (1973) 1.02
Vascular problems in upper abdominal cancer surgery. Arch Surg (1974) 1.02
A new concept for hepatic lobectomy. Experimental studies and clinical application. Arch Surg (1971) 0.94
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96
The epidemiology of lung cancer. Recent trends. JAMA (1970) 3.53
Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery (1986) 3.22
Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol (2000) 2.96
Myosarcomas of the stomach: natural history, prognostic factors and management. Cancer (1982) 2.85
Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg (1978) 2.80
Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer (1990) 2.74
A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol (1989) 2.71
Giant hemangiomas of the liver. Ann Surg (1970) 2.70
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol (1988) 2.63
Orthotopic and heterotopic liver homografts in man. Ann Surg (1970) 2.63
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer (1989) 2.62
Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol (1985) 2.56
Regional resection of cancer of the pancreas: a new surgical approach. Surgery (1973) 2.43
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta (2001) 2.41
Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc Natl Acad Sci U S A (2000) 2.41
Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39
Epidemiology of cancer of the pancreas. J Natl Cancer Inst (1973) 2.37
Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg (1975) 2.31
Malignant schwannoma. A clinicopathologic study. Cancer (1973) 2.26
Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum (1988) 2.20
A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis (1986) 2.09
Malignant schwannoma--clinical characteristics, survival, and response to therapy. Cancer (1981) 2.04
Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann Surg (1984) 2.03
Cellular schwannoma. A clinicopathologic study of 57 patients and 58 tumors. Cancer (1990) 1.97
Elderly applicants to long-term care institutions. I. Their characteristics, health problems and state of mind. J Am Geriatr Soc (1976) 1.96
Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg (1977) 1.96
The continuing challenge of retroperitoneal sarcomas. Cancer (1981) 1.95
Breast self-examination and medical examination related to breast cancer stage. Am J Public Health (1981) 1.92
Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg (1995) 1.91
Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size. Ann Surg (1981) 1.90
Local recurrence in adult soft-tissue sarcoma. A randomized trial of brachytherapy. Arch Surg (1987) 1.88
The case for and technique of heterotopic liver grafting. Transplant Proc (1979) 1.87
Sarcoma of the breast. A study of 32 patients with reappraisal of classification and therapy. Ann Surg (1985) 1.87
Angiosarcoma and other vascular tumors of the breast. Am J Surg Pathol (1981) 1.86
The role of multimodality therapy in soft-tissue sarcoma. Ann Surg (1991) 1.85
Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol (1993) 1.83
Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis (1990) 1.82
FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH. Mol Cell (2000) 1.82
Primary tumors and tumor-like lesions of the clavicle. Skeletal Radiol (1988) 1.77
Generation of human monoclonal antibodies reactive with cellular antigens. Proc Natl Acad Sci U S A (1983) 1.71
Multicentricity and bilaterality in invasive breast carcinoma. Surgery (1982) 1.69
Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery (1997) 1.68
The seventies evolution in liver surgery for cancer. Cancer (1981) 1.68
Multiple pulmonary resections in the treatment of osteogenic sarcoma. Ann Thorac Surg (1971) 1.67
The desmoid tumor. Not a benign disease. Arch Surg (1989) 1.66
Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology (2000) 1.65
Carcinoma of the trachea. Clinicopathologic study of 41 cases. Cancer (1970) 1.65
The role of the pathologist in the management of soft tissue sarcomas. World J Surg (1988) 1.64
Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg (1991) 1.64
Lipoma of the large intestine: a review of 45 cases. Dis Colon Rectum (1973) 1.60
Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem (2000) 1.60
Podocyte biology in diabetic nephropathy. Kidney Int Suppl (2007) 1.58
Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol (1989) 1.57
Isoform-specific interaction of the alpha1A subunits of brain Ca2+ channels with the presynaptic proteins syntaxin and SNAP-25. Proc Natl Acad Sci U S A (1996) 1.56
Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections. Ann Surg (1983) 1.53
Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy. Ann Surg (1973) 1.53
Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52
The malignant potential of bronchial adenoma. Ann Thorac Surg (1972) 1.51
Limited surgery and radiotherapy for early breast cancer. N Engl J Med (1985) 1.48
Preoperative hyperfractionated radiotherapy with concurrent chemotherapy in resectable esophageal cancer. Int J Radiat Oncol Biol Phys (2001) 1.46
Transverse myelitis after measles and rubella vaccination. J Paediatr Child Health (2004) 1.45
High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer (1974) 1.44
Automation and integration of components for generalized semantic markup of electronic medical texts. Proc AMIA Symp (1999) 1.44
Clinical and angiographic follow-up of spontaneous isolated superior mesenteric artery dissection. Eur J Vasc Endovasc Surg (2009) 1.43
Clinical manifestations of hepatoma. A review of 6 years' experience at a cancer hospital. Am J Med (1974) 1.42
Development of the Korean versions of WHO Quality of Life scale and WHOQOL-BREF. Qual Life Res (2002) 1.42
Endoscopic diagnosis of advanced gastric cancer. Factors influencing yield. Gastroenterology (1975) 1.40
Iron supplementation inhibits cough associated with ACE inhibitors. Hypertension (2001) 1.39
Brain metastases in malignant pleural mesothelioma. Case report and review of the literature. Am J Clin Oncol (1989) 1.39
Myosarcomas of the small and large intestine: a clinicopathologic study. J Surg Oncol (1983) 1.39
Carcinoma of large intestine in patients irradiated for carcinoma of cervix and uterus. Cancer (1973) 1.38
Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg (1983) 1.36
Male breast cancer: a clinicopathologic study of 97 cases. Ann Surg (1978) 1.34
Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery (1989) 1.34
Tumors of the major salivary glands in children. Cancer (1972) 1.33
Estrogen receptor protein in breast cancer as a predictor of recurrence. Cancer (1981) 1.33
Hamartomas of the lung. Surg Gynecol Obstet (1973) 1.33
Tracheoesophageal fistula due to cancer. J Thorac Cardiovasc Surg (1970) 1.33
The role of radiotherapy in the management of malignant hemangiopericytoma: report of eleven new cases and review of the literature. Cancer (1977) 1.33
Ten-year results of the treatment of primary operable breast carcinoma: A summary of 304 patients evaluated by the TNM system. Cancer (1976) 1.32